EVA Live Signals Bold Pivot with AI Launch and Potential Share Buyback

LOS ANGELES, CA – February 09, 2026 – In a significant strategic pivot, AI-driven advertising company EVA Live, Inc. (Nasdaq: GOAI) has signaled a move from a decade of development into full-scale commercialization, underpinned by bold financial maneuvers that project strong internal confidence. A recent letter to shareholders from Founder and CEO David Boulette outlined the company's new chapter, centered on the official launch of its NeuroServer AI platform, a disciplined growth strategy, and a potential share repurchase program.

This series of announcements follows the company's recent, and volatile, uplisting to the Nasdaq Stock Market. Having spent years building its proprietary technology, EVA Live is now making a concerted push to translate its technological assets into market share and shareholder value, a move that Wall Street is watching with a mix of excitement and caution.

A New Chapter on a Major Exchange

EVA Live's strategic shift comes just weeks after its transition from the OTCQB venture market to the Nasdaq Stock Market, which commenced on January 28, 2026. The move was intended to enhance the company's visibility and improve stock liquidity. The market's initial reaction was explosive, with premarket trading on its debut day showing surges of over 400%, and the stock ultimately closing its first session up 27%.

However, the initial euphoria was short-lived. The stock saw significant declines in the subsequent trading days, falling over 29% on January 29 and another 27% the following day. This volatility highlights the market's complex view of the company. While the Nasdaq listing and AI narrative are compelling, the stock's wide 52-week trading range of $1.32 to $18.00 suggests investors are still weighing the firm's promising future against a history that includes deep-seated risk perception and past losses.

The NeuroServer Gambit

At the heart of EVA Live's commercialization strategy is NeuroServer, its newly launched, next-generation AI-powered advertising platform. According to the company, the platform is the culmination of nearly a decade of in-house development and is designed to “automate, optimize, and scale” digital advertising performance. The system aims to replace manual campaign management with AI-driven, real-time optimization for ad targeting and media buying.

“With the NeuroServer now live, we are shifting from development into full commercialization,” Boulette stated in his letter. “This platform is designed to be a core driver of future revenue and gives us the ability to scale advertising performance for customers.”

The challenge for EVA Live will be carving out a niche in the fiercely competitive adtech landscape, a domain dominated by giants like Google, Meta, and programmatic advertising leader The Trade Desk. These established players have their own sophisticated AI engines fueled by massive datasets. EVA Live is betting that its proprietary technology and extensive data processing capabilities—which it claims include analyzing 29 billion US searches per month and managing over 100 million daily display impressions—will provide a crucial competitive edge. The success of this pivot hinges on NeuroServer's ability to deliver demonstrably superior results in this crowded field.

A Bold Financial Stance

Perhaps the most telling signal of management's confidence is the company's recent capital management decisions. EVA Live announced it has withdrawn its previously filed Form S-1 registration statement, a document that signals intent to raise capital through a public offering of stock. By shelving the S-1, the company is forgoing a potential infusion of external cash, a move that avoids diluting the value of existing shares.

Boulette's letter cited the company's “current financial position and operating momentum” as the reason for the withdrawal, emphasizing a focus on executing its growth strategy with “disciplined capital management.” This confidence appears rooted in strong recent performance. Prior to its uplisting, EVA Live reported an 83% revenue increase last year to $9.33 million and achieved significant profitability in the first half of 2025, with a net income of $4.62 million on revenues of $7.82 million.

This recent turn to profitability marks a stark contrast to previous years, including a substantial loss during the 2022 “Inflation Shock,” which helps explain lingering market skepticism. The company's new mantra of disciplined growth and financial self-reliance is a direct message to investors that it plans to fund its expansion internally, believing its current operations are strong enough to support its ambitions.

Betting on Themselves: Share Repurchases and Growth

Further reinforcing this message of self-belief, EVA Live is now evaluating a potential share repurchase program. While subject to board approval and market conditions, a buyback is a classic corporate finance tool used to return cash to shareholders and signal that management believes its stock is undervalued. By reducing the number of shares outstanding, a repurchase program can increase earnings per share and potentially boost the stock price.

“This reflects management’s confidence in the business and its long-term direction,” the company stated. This move, combined with the S-1 withdrawal, paints a clear picture of a leadership team that is betting on its own ability to execute.

To support this next phase, EVA Live has also expanded its engineering, product, and business development teams with experienced industry professionals. The stated goal is to scale sales, accelerate product development, and meet growing customer demand. As the company leaves its development phase behind, all eyes will be on its upcoming quarterly results to see if the promise of its NeuroServer platform can be converted into the disciplined, scalable, and profitable growth that its leadership is so confidently forecasting.